Fremont, CA, United States of America

Shanti Gonela Duvur

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cytomx Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shanti Gonela Duvur. Retrieved from https://idiyas.com/inventor/shanti-gonela-duvur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shanti Gonela Duvur: Innovator in Antibody Technology

Introduction

Shanti Gonela Duvur is a notable inventor based in Fremont, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibody compositions. His work is characterized by a focus on enhancing the functionality of antibodies for therapeutic applications.

Latest Patents

Duvur holds a patent for "Compositions containing activatable antibodies." This invention provides a composition that includes an intact activatable antibody and a clipped variant thereof. The patent also outlines methods for separating clipped variants from intact activatable antibodies and techniques for monitoring the relative percentages of these components during the production process.

Career Highlights

Shanti Gonela Duvur is currently employed at CytomX Therapeutics, Inc., where he continues to advance his research in antibody technology. His innovative approach has positioned him as a key player in the biotechnology sector.

Collaborations

Duvur collaborates with talented professionals such as Sarah Patrick and Claus Krebber. These partnerships enhance the research and development efforts at CytomX Therapeutics, Inc.

Conclusion

Shanti Gonela Duvur's contributions to antibody technology exemplify the innovative spirit of modern biotechnology. His work not only advances scientific understanding but also holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…